机构

• 上海药物研究所 [14]

采集方式

• OAI收割 [14]

内容类型

• 期刊论文 [14]

发表日期

• 2023 [3]
• 2022 [1]
• 2020 [4]
• 2019 [1]
• 2018 [3]
• 2017 [2]
• 更多

学科主题

筛选

浏览/检索结果: 共14条，第1-10条 帮助 限定条件 专题：上海药物研究所    第一署名单位    第一作者单位    通讯作者单位     条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序发表日期升序发表日期降序题名升序题名降序作者升序作者降序 Dihydrocelastrol induces antitumor activity and enhances the sensitivity of bortezomib in resistant multiple myeloma by inhibiting STAT3-dependent PSMB5 regulation 期刊论文  OAI收割 ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2023, 卷号: 55, 期号: 12, 页码: 1884-1891 作者:  Jin, Shuhan;  Li, Bo;  Zhang, Bibo;  Gao, Xuejie;  Jia, Xinyan   |  收藏  |  浏览/下载：8/0  |  提交时间：2024/02/27 dihydrocelastrol  multiple myeloma  JAK2/STAT3  PSMB5  bortezomib resistance   The novel norcantharidin derivative DCZ5417 suppresses multiple myeloma progression by targeting the TRIP13-MAPK-YWHAE signaling pathway 期刊论文  OAI收割 JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 卷号: 21, 期号: 1, 页码: 17 作者:  Wang, Yingcong;  Dong, Sanfeng;  Hu, Ke;  Xu, Li;  Feng, Qilin   |  收藏  |  浏览/下载：12/0  |  提交时间：2024/01/26 Norcantharidin  Derivative  DCZ5417  TRIP13  Anti-myeloma  MAPK   Aberrant activation of TRIP13-EZH2 signaling axis promotes stemness and therapy resistance in multiple myeloma 期刊论文  OAI收割 LEUKEMIA, 2023, 页码: 4 作者:  Xu, Li;  Wang, Yingcong;  Wang, Guanli;  Guo, Shushan;  Yu, Dandan   |  收藏  |  浏览/下载：22/0  |  提交时间：2023/10/17 Preclinical validation and phase I trial of 4-hydroxysalicylanilide, targeting ribonucleotide reductase mediated dNTP synthesis in multiple myeloma 期刊论文  OAI收割 Journal of Biomedical Science, 2022, 卷号: 29, 期号: 1 作者:  Xie,Yongsheng;  Wang,Yingcong;  Xu,Zhijian;  Lu,Yumeng;  Song,Dongliang   |  收藏  |  浏览/下载：27/0  |  提交时间：2022/06/15 4-Hydroxysalicylanilid  Ribonucleotide reductase  Deoxyribonucleotides  DNA damage repair  Multiple myeloma   A novel M phase blocker, DCZ3301 enhances the sensitivity of bortezomib in resistant multiple myeloma through DNA damage and mitotic catastrophe 期刊论文  OAI收割 Journal of Experimental & Clinical Cancer Research, 2020, 卷号: 39, 期号: 1 作者:  Hu,Liangning;  Li,Bo;  Chen,Gege;  Song,Dongliang;  Xu,Zhijian   |  收藏  |  浏览/下载：44/0  |  提交时间：2020/07/01 Multiple myeloma  Drug-resistance  DNA damage response  Cell cycle   A novel phosphoramide compound, DCZ0847, displays in vitro and in vivo anti-myeloma activity, alone or in combination with bortezomib 期刊论文  OAI收割 CANCER LETTERS, 2020, 卷号: 478, 页码: 45-55 作者:  Chen, Gege;  Hu, Ke;  Sun, Haiguo;  Zhou, Jinfeng;  Song, Dongliang   |  收藏  |  浏览/下载：31/0  |  提交时间：2020/07/01 Multiple myeloma  Bone marrow microenvironment  DNA damage  JAK2/STAT3 pathway   A novel silicone derivative of natural osalmid (DCZ0858) induces apoptosis and cell cycle arrest in diffuse large B-cell lymphoma via the JAK2/STAT3 pathway 期刊论文  OAI收割 SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2020, 卷号: 5, 期号: 1, 页码: 11 作者:  Lu, Kang;  Li, Bo;  Zhang, Hui;  Xu, Zhijian;  Song, Dongliang   |  收藏  |  浏览/下载：29/0  |  提交时间：2020/07/01 A Small-Molecule Inhibitor Targeting TRIP13 Suppresses Multiple Myeloma Progression 期刊论文  OAI收割 CANCER RESEARCH, 2020, 卷号: 80, 期号: 3, 页码: 536-548 作者:  Wang, Yingcong;  Huang, Jing;  Li, Bo;  Xue, Han;  Tricot, Guido   |  收藏  |  浏览/下载：42/0  |  提交时间：2020/07/01 DCZ0814 induces apoptosis and G0/G1 phase cell cycle arrest in myeloma by dual inhibition of mTORC1/2 期刊论文  OAI收割 CANCER MANAGEMENT AND RESEARCH, 2019, 卷号: 11, 页码: 4797-4808 作者:  Kong, Yuanyuan;  Li, Bo;  Chang, Shuaikang;  Gao, Lu;  Xu, Zhijian   |  收藏  |  浏览/下载：16/0  |  提交时间：2020/07/01 DCZ0814  multiple myeloma  mTOR  bone marrow microenvironment  apoptosis   Rafoxanide, an organohalogen drug, triggers apoptosis and cell cycle arrest in multiple myeloma by enhancing DNA damage responses and suppressing the p38 MAPK pathway 期刊论文  OAI收割 Cancer letters, 2018, 卷号: 444, 页码: 45-59 作者:  Xiao, Wenqin;  Xu, Zhijian;  Chang, Shuaikang;  Li, Bo;  Yu, Dandan   |  收藏  |  浏览/下载：98/0  |  提交时间：2019/01/08